Table of Contents >> Show >> Hide
- What “33 times a week” really means
- Prior authorization: The paperwork wall between patients and care
- Why doctors say denials can harm patients
- Insurance companies say they are controlling costs
- Where profit enters the conversation
- The appeal problem: Patients often do not fight back
- How prior authorization fuels physician burnout
- The role of AI and automation in insurance denials
- What real reform should look like
- What patients can do when insurance denies care
- Experiences from the front lines: What this battle feels like
- Conclusion: Care should not depend on who can fight the longest
Note: This article is written for general informational and editorial purposes. It is not medical, legal, or insurance advice.
In American medicine, a doctor can examine a patient, make a diagnosis, choose an evidence-based treatment, explain the plan, answer the family’s anxious questions, and then run face-first into the most powerful person in the room: the insurance company’s approval system.
That is the heart of the debate behind the phrase “Insurance profits over patients’ lives: Doctors battle for proper care 33 times a week.” The number reflects a painful reality many physicians know too well: care decisions are increasingly filtered through prior authorization, claim reviews, step therapy requirements, medical necessity disputes, and appeals. In plain English, doctors often have to ask permission before giving patients the care they believe is appropriate.
And the situation has not exactly improved with age, like a fine cheese. Recent physician surveys suggest the weekly burden has climbed even higher, with many practices now handling around 40 prior authorization requests per physician each week. That is not a tiny clerical hiccup. That is a second job wearing a lab coat and carrying a fax machine from 1998.
What “33 times a week” really means
The phrase “33 times a week” is not just a dramatic headline. It captures the repeated battles physicians describe when they try to secure approval for medications, imaging, procedures, specialist care, hospital stays, rehabilitation, or follow-up services. Each request can involve forms, clinical notes, phone calls, portals, peer-to-peer reviews, denials, resubmissions, and appeals.
For patients, this administrative maze may look invisible until it blocks something important. A dermatologist may prescribe a medication because a patient has severe acne that is likely to scar, only to be told the patient must first try a cheaper antibiotic. An oncologist may recommend a scan, but the insurer may demand more documentation. A primary care doctor may refer a patient for physical therapy, only to discover that approval has been delayed long enough for the patient’s condition to worsen.
The insurer’s explanation often sounds reasonable on paper: prior authorization is supposed to prevent unnecessary, unsafe, or wasteful care. In theory, that is not a villainous idea. Nobody wants useless procedures, unsafe prescribing, or runaway costs. But in practice, the system often functions less like a safety check and more like a locked door with a very tired doctor rattling the handle.
Prior authorization: The paperwork wall between patients and care
Prior authorization requires clinicians to obtain an insurer’s approval before certain treatments or services are covered. The process is common in private insurance, Medicare Advantage, Medicaid managed care, and marketplace plans. It can apply to expensive medications, imaging tests, surgeries, home health services, durable medical equipment, inpatient care, behavioral health treatment, and specialty drugs.
On paper, prior authorization is a utilization management tool. In real life, it can become a time-consuming negotiation over whether a patient gets care now, care later, or no covered care at all.
The hidden cost is time
Physicians and their teams spend hours each week managing prior authorization. That time comes from somewhere. It may come from appointment availability, patient phone calls, charting, care coordination, or the doctor’s ability to eat lunch like a mammal rather than a raccoon standing over a keyboard.
When a medical practice has to hire staff just to manage insurance approvals, the cost does not disappear. It becomes part of the larger healthcare expense machine. Patients feel it through longer waits, burned-out clinicians, rushed visits, and higher administrative overhead.
The emotional cost is harder to measure
For patients, a denial letter can feel like a verdict. Even when the denial is later overturned, the delay can create fear, confusion, and financial pressure. Patients may wonder whether their doctor was wrong, whether the treatment is truly necessary, or whether they should simply give up. Many do give up, especially when they are sick, exhausted, working hourly jobs, caring for children, or unable to spend three afternoons on hold.
For doctors, the frustration is different but just as real. They train for years to diagnose and treat illness, only to spend part of the week defending basic medical judgment to a system that may not fully understand the patient in front of them.
Why doctors say denials can harm patients
Doctors are not complaining because they dislike paperwork. Nobody enjoys paperwork, of course, but physicians have made peace with a lot of it. They complain because delays and denials can change patient outcomes.
A delayed MRI may postpone a diagnosis. A denied medication may force a patient to cycle through cheaper alternatives that have already failed. A blocked rehabilitation service may slow recovery after surgery. A delayed hospital transfer may leave a patient in the wrong care setting. In chronic illness, interruptions can be especially damaging because stability is often hard-won and easy to lose.
Consider diabetes, rheumatoid arthritis, cancer, multiple sclerosis, inflammatory bowel disease, severe acne, depression, or heart disease. In these conditions, timely care matters. A patient who is stable on a medication may deteriorate if coverage suddenly changes. A person waiting for diagnostic imaging may lose precious time. A patient asked to “fail first” on a cheaper therapy may suffer avoidable pain, scarring, disease progression, or anxiety.
Insurance companies say they are controlling costs
To be fair, insurers do have a real problem to solve. American healthcare is expensive. Some care is unnecessary. Some treatments are overused. Some prices are wildly inflated, as if a hospital billing department once looked at a simple bandage and thought, “What if this were a luxury yacht?”
Insurers argue that prior authorization helps ensure care is medically necessary, evidence-based, and cost-effective. They also say reforms are underway. Several major health plans have pledged to reduce prior authorization requirements, improve transparency, speed decisions, support electronic submissions, and provide more continuity when patients change coverage.
Those promises matter. Faster electronic systems could reduce some pain. Clearer denial explanations could help patients and doctors appeal more effectively. Reducing the number of services requiring prior authorization could free clinicians to focus on care instead of clerical combat.
But doctors remain skeptical because they have heard promises before. They want measurable change: fewer unnecessary denials, faster approvals, real clinical review, transparent criteria, and accountability when wrong denials delay medically necessary care.
Where profit enters the conversation
The phrase “insurance profits over patients’ lives” is emotionally charged, but it speaks to a structural tension. Insurers collect premiums and pay claims. The less they pay out relative to premiums and administrative costs, the better their financial performance may look. That does not mean every denial is malicious. It does mean the incentives are complicated.
When an insurance company delays or denies a service, several things may happen. Some patients appeal and win. Some appeal and lose. Some never appeal because the process is confusing or exhausting. Some pay out of pocket. Some abandon treatment. From a patient’s point of view, the motive may not matter much. The practical result is the same: the recommended care becomes harder to obtain.
This is why overturned denials are so troubling. If a denial is reversed on appeal, it raises an obvious question: why was the patient forced through the delay in the first place? In Medicare Advantage, millions of prior authorization requests are denied each year, while a high share of appealed denials are later overturned. That pattern suggests the appeal system can work, but only for patients and doctors who have the time, knowledge, stamina, and documentation to fight.
The appeal problem: Patients often do not fight back
Appeals are one of the most underused tools in healthcare. Many patients do not know they can appeal. Others assume the insurer’s decision is final. Some are too overwhelmed by illness to challenge the denial. Others are intimidated by forms, deadlines, and medical language.
This creates a quiet imbalance. Insurers have professional systems for issuing and processing denials. Patients often have a kitchen table, a stack of confusing papers, and a phone number that leads to hold music capable of aging a person three years.
Doctors and medical staff frequently step in to help. They write letters of medical necessity, send records, join peer-to-peer calls, and explain why the recommended treatment is appropriate. But every hour spent appealing is an hour not spent directly caring for patients. The system turns healers into part-time insurance litigators, except without the billable hours or the dramatic courtroom soundtrack.
How prior authorization fuels physician burnout
Physician burnout is often discussed as if it comes from long hours alone. Long hours matter, but moral distress may matter even more. Moral distress happens when clinicians know what a patient needs but are blocked from providing it by forces outside the exam room.
A doctor can accept hard medical limits. A disease may be advanced. A treatment may not exist. A patient may have a complex risk profile. Those are clinical realities. What is harder to accept is watching a patient wait because a covered benefit is trapped behind an administrative gate.
Burnout also affects patients. A burned-out physician may leave practice, reduce hours, or stop accepting certain insurance plans. That worsens access, especially in primary care, dermatology, psychiatry, oncology, rheumatology, and other specialties already facing shortages in many regions.
The role of AI and automation in insurance denials
Automation could make prior authorization better, or it could make it colder. Electronic prior authorization can speed approvals when systems are designed well. A request that once took days could move in minutes if the needed clinical information is available and the rules are clear.
But automation also raises concerns. If insurers use algorithms to deny or delay care at scale, physicians worry that patients may face faster rejection rather than faster access. Technology should reduce friction, not become a digital bouncer standing between patients and medically necessary care.
The best version of automation would make simple approvals nearly instant, flag truly questionable requests for qualified clinical review, and provide clear explanations when coverage is denied. The worst version would bury doctors in automated denials, vague criteria, and appeals that feel like shouting into a well.
What real reform should look like
Meaningful reform does not require eliminating every insurance review. It requires making the process fair, fast, transparent, and clinically credible.
1. Fewer services should require prior authorization
Prior authorization should be reserved for areas where there is genuine risk of overuse, safety concern, or major cost variation. Routine, evidence-based care should not be trapped in repeated approval cycles.
2. Approved care should stay approved
Patients with chronic conditions should not have to restart the approval battle every few months for a treatment that is working. Continuity matters, especially when a coverage disruption can trigger relapse, pain, hospitalization, or disease progression.
3. Denials should be specific and understandable
A vague denial is not transparency. Patients and clinicians need clear reasons, the exact policy criteria used, the records reviewed, and the steps required to appeal.
4. Peer review should involve real peers
If a specialist’s recommendation is challenged, the reviewer should have relevant clinical expertise. A dermatologist’s treatment plan should not be casually overruled by someone with no dermatology experience. “Trust me, I read the dropdown menu” is not clinical review.
5. Insurers should be accountable for harmful delays
If a plan repeatedly denies care that is later overturned, regulators and purchasers should pay attention. Employers, government programs, and consumers need access to denial rates, appeal outcomes, turnaround times, and complaint patterns.
What patients can do when insurance denies care
Patients should not have to become experts in insurance law to receive medical care. Still, a few practical steps can help. First, ask for the denial in writing. Second, request the exact reason and the policy criteria used. Third, ask the doctor’s office whether a letter of medical necessity, peer-to-peer review, or appeal is appropriate. Fourth, keep a record of dates, names, reference numbers, and submitted documents. Fifth, do not assume the first denial is the final answer.
Patients can also contact their employer’s benefits department, state insurance department, Medicare plan resources, marketplace assistance programs, or patient advocacy organizations. The right path depends on the type of insurance, but the central principle is simple: challenge decisions that do not make sense.
Experiences from the front lines: What this battle feels like
One of the most painful parts of insurance battles is how ordinary they become. A patient may walk into a clinic thinking the hard part is getting diagnosed. Then the doctor says, “I know what we should do next,” and everyone briefly feels hopeful. The plan is clear. The treatment exists. The prescription is available. The imaging center has an opening. Then comes the sentence patients learn to dread: “We just need insurance approval.”
From that moment, the patient’s medical journey can turn into an administrative scavenger hunt. The pharmacy says the medication needs prior authorization. The insurer says it never received the paperwork. The doctor’s office says it was submitted twice. The portal says the request is pending. The representative says the decision will arrive in three to five business days, a phrase that has never comforted anyone in pain.
For a working parent, that delay may mean taking more unpaid time off. For an older adult, it may mean asking an adult child to call the insurer because the forms are confusing. For a cancer patient, it may mean lying awake wondering whether a scan delay will change the course of treatment. For someone with depression, it may mean losing the energy to keep fighting at all.
Doctors experience the battle differently. They may know the treatment is appropriate, but they also know the insurer may demand proof in a very specific format. They dictate notes carefully, attach lab results, document failed therapies, and explain why cheaper alternatives are not suitable. Sometimes the denial still arrives. Then comes the peer-to-peer call, which may or may not involve a reviewer trained in the same specialty. If the doctor is lucky, the call ends with approval. If not, the cycle continues.
Medical assistants, nurses, and billing staff often carry the invisible workload. They remember which insurer requires which portal, which plan wants which form, and which denial language usually means an appeal has a chance. Their work is essential, but it is also exhausting. They are not just moving paperwork. They are trying to keep patients from falling through cracks built into the system.
Patients who can pay out of pocket may bypass some delays, but that creates another ethical problem. The same medical recommendation becomes available faster to people with money. Those without savings may wait, switch to a less effective option, or skip care altogether. Insurance is supposed to protect people from financial catastrophe, not create a velvet rope outside the treatment room.
There are also success stories. A denied scan gets approved after a physician appeal. A medication is covered after documentation shows previous treatments failed. A patient learns to request written denials and wins an external review. These victories matter, but they also reveal the flaw. A system should not require heroic persistence to produce ordinary care.
The deepest frustration is that most people involved in healthcare want patients to get better. Doctors want to treat. Nurses want to coordinate. Pharmacists want to fill prescriptions safely. Patients want to heal. Even many people working inside insurance companies are trying to follow rules in a massive, complicated machine. The problem is the machine itself: too opaque, too slow, too comfortable with delay, and too willing to transfer the burden onto sick people and the clinicians caring for them.
That is why the phrase “insurance profits over patients’ lives” resonates. It names the fear patients feel when a financial system appears to outrank a clinical one. It names the anger doctors feel when expertise is second-guessed by paperwork. And it names the urgent need for reform that is not cosmetic, not optional, and not buried in another cheerful press release about “streamlining.” Patients do not need streamlining as a slogan. They need care that arrives on time.
Conclusion: Care should not depend on who can fight the longest
The battle over prior authorization and insurance denials is not just a dispute between doctors and health plans. It is a test of what American healthcare is supposed to be. If the system rewards delay, opacity, and exhaustion, patients lose. If it respects medical judgment, demands transparency, and holds insurers accountable, patients have a better chance.
Insurance companies are right that costs matter. But costs are not the only measure of value. A denied medication, a delayed diagnosis, a missed therapy session, or an abandoned treatment plan can create downstream costs that are financial, clinical, and deeply human.
Doctors should not have to battle dozens of times a week to deliver proper care. Patients should not have to become professional appeal writers while sick. And healthcare should not feel like a contest where the winner is whoever can survive the most hold music.
The path forward is not mysterious. Reduce unnecessary prior authorization. Speed up approvals. Make denials transparent. Use qualified reviewers. Publish meaningful data. Protect continuity of care. And above all, remember that behind every request number is a person waiting for help.
